220 related articles for article (PubMed ID: 36778772)
1. Diagnostic potential of salivary interleukin-17, RANKL, and OPG to differentiate between periodontal health and disease and discriminate stable and unstable periodontitis: A case-control study.
Abdullameer MA; Abdulkareem AA
Health Sci Rep; 2023 Feb; 6(2):e1103. PubMed ID: 36778772
[TBL] [Abstract][Full Text] [Related]
2. Salivary interleukin-1β as a biomarker to differentiate between periodontal health, gingivitis, and periodontitis.
Abdullameer MA; Abdulkareem AA
Minerva Dent Oral Sci; 2023 Oct; 72(5):221-229. PubMed ID: 37162330
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Salivary RANKL and OPG Levels in Periodontitis Patients at Hospital Universiti Sains Malaysia.
Asif S; Ahmad B; Hamza SA; Taib H; Kassim NK; Zainuddin SLA
Eur J Dent; 2022 Feb; 16(1):173-178. PubMed ID: 34571567
[TBL] [Abstract][Full Text] [Related]
4. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
5. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles of Interleukin-34 together with receptor activator of nuclear factor-kB ligand and osteoprotegerin levels in periodontal disease.
Bozkurt Doğan Ş; Öngöz Dede F; Ballı U; Sertoğlu E
Cytokine; 2021 Aug; 144():155584. PubMed ID: 34034144
[TBL] [Abstract][Full Text] [Related]
7. Salivary soluble receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio in periodontal disease and health.
Tabari ZA; Azadmehr A; Tabrizi MA; Hamissi J; Ghaedi FB
J Periodontal Implant Sci; 2013 Oct; 43(5):227-32. PubMed ID: 24236245
[TBL] [Abstract][Full Text] [Related]
8. Association of salivary RANKL and osteoprotegerin levels with periodontal health.
Ochanji AA; Matu NK; Mulli TK
Clin Exp Dent Res; 2017 Apr; 3(2):45-50. PubMed ID: 29744178
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of salivary biomarkers for the diagnosis of periodontitis.
Zhang Y; Kang N; Xue F; Qiao J; Duan J; Chen F; Cai Y
BMC Oral Health; 2021 May; 21(1):266. PubMed ID: 34001101
[TBL] [Abstract][Full Text] [Related]
10. Saliva concentrations of RANKL and osteoprotegerin in smoker versus non-smoker chronic periodontitis patients.
Buduneli N; Biyikoğlu B; Sherrabeh S; Lappin DF
J Clin Periodontol; 2008 Oct; 35(10):846-52. PubMed ID: 18727653
[TBL] [Abstract][Full Text] [Related]
11. Salivary bactericidal/permeability-increasing protein: A novel inflammatory marker associated with periodontitis.
Demirci MB; Daltaban Ö; Üstün K
Clin Oral Investig; 2023 Jun; 27(6):3159-3167. PubMed ID: 36805805
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis.
Giannopoulou C; Martinelli-Klay CP; Lombardi T
Acta Odontol Scand; 2012 Dec; 70(6):629-34. PubMed ID: 22214279
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Salivary Levels of RANKL and OPG in Aggressive versus Chronic Periodontitis.
Teodorescu AC; Martu I; Teslaru S; Kappenberg-Nitescu DC; Goriuc A; Luchian I; Martu MA; Solomon SM; Mârțu S
J Immunol Res; 2019; 2019():6195258. PubMed ID: 31183390
[TBL] [Abstract][Full Text] [Related]
14. The expression levels of MicroRNA-146a, RANKL and OPG after non-surgical periodontal treatment.
Sattari M; Taheri RA; ArefNezhad R; Motedayyen H
BMC Oral Health; 2021 Oct; 21(1):523. PubMed ID: 34645448
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis.
Mogi M; Otogoto J; Ota N; Togari A
J Dent Res; 2004 Feb; 83(2):166-9. PubMed ID: 14742657
[TBL] [Abstract][Full Text] [Related]
16. Salivary Colony Stimulating Factor-1 and Interleukin-34 in Periodontal Disease.
Martinez GL; Majster M; Bjurshammar N; Johannsen A; Figueredo CM; Boström EA
J Periodontol; 2017 Aug; 88(8):e140-e149. PubMed ID: 28474967
[TBL] [Abstract][Full Text] [Related]
17. Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis.
Baltacıoğlu E; Kehribar MA; Yuva P; Alver A; Atagün OS; Karabulut E; Akalın FA
J Periodontol; 2014 Feb; 85(2):317-26. PubMed ID: 23701481
[TBL] [Abstract][Full Text] [Related]
18. Levels of Pro-Inflammatory and Bone-Resorptive Mediators in Periodontally Compromised Patients under Orthodontic Treatment Involving Intermittent Forces of Low Intensities.
Navarrete C; Riquelme A; Baksai N; Pérez R; González C; Michea M; von Mühlenbrock H; Cafferata EA; Vernal R
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902236
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Initial Periodontal Therapy on the Serum Receptor Activator of Nuclear Factor-κβ Ligand/Osteoprotegerin System in Patients With Type 2 Diabetes Mellitus and Periodontitis.
Xu JL; Meng HX; He L; Wang XE; Zhang L
J Periodontol; 2016 Mar; 87(3):303-11. PubMed ID: 26561998
[TBL] [Abstract][Full Text] [Related]
20. RANKL and OPG mRNA level after non-surgical periodontal treatment.
Dereka XE; Markopoulou CE; Fanourakis G; Tseleni-Balafouta S; Vrotsos IA
Inflammation; 2010 Jun; 33(3):200-6. PubMed ID: 20033478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
